Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|August 27, 2014
PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolatesS Wesley Long, Randall J Olsen, Shrenik C Mehta, et al.
Scientific Reports|January 12, 2018
Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniaeMarcus Nguyen, Thomas Brettin, S Wesley Long, et al.
Journal of Clinical Microbiology|September 26, 2014
Clinical laboratory response to a mock outbreak of invasive bacterial infections: a preparedness studyRandall J Olsen, Nahuel Fittipaldi, Priyanka Kachroo, et al.
Veterinary Parasitology|September 12, 2006
A preliminary investigation of Ehrlichia species in ticks, humans, dogs, and capybaras from BrazilMarcelo B Labruna, Jere W McBride, Luis Marcelo A Camargo, et al.
The American Journal of Pathology|March 20, 2021
Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of ConcernS Wesley Long, Randall J Olsen, Paul A Christensen, et al.
Infection and Immunity|September 30, 2015
The majority of 9,729 group A streptococcus strains causing disease secrete SpeB cysteine protease: pathogenesis implicationsRandall J Olsen, Anjali Raghuram, Concepcion Cantu, et al.
Archives of Pathology & Laboratory Medicine|September 3, 2011
Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated responseAngela M Wright, Stephen B Beres, Erin N Consamus, et al.
The American Journal of Pathology|July 25, 2021
Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome SequencesRandall J Olsen, Paul A Christensen, S Wesley Long, et al.
The American Journal of Pathology|February 6, 2022
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, TexasPaul A Christensen, Randall J Olsen, S Wesley Long, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2014
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequencesWaleed Nasser, Stephen B Beres, Randall J Olsen, et al.
Pageof 6